Pharmaxis Ltd PMXSF
Set alert
At close · Feb 4
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.026
- Prev close
- 0.026
- Mkt cap
- 31.04M
- Vol
- 150.00K
- Avg vol
- 98.28K
- EPS
- -0.003736
- P/E
- -6.96
More statistics
- Low
- 0.026
- High
- 0.026
News
3 months ago seekingalpha.com
Syntara Limited (PMXSF) Q4 2026 Earnings Call Transcript
Syntara Limited (PMXSF) Q4 2026 Earnings Call Transcript
3 months ago seekingalpha.com
Syntara Limited (PMXSF) Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder Transcript
Syntara Limited (PMXSF) Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder Transcript
4 months ago seekingalpha.com
Syntara Limited (PMXSF) Shareholder/Analyst Call Prepared Remarks Transcript
Syntara Limited (PMXSF) Shareholder/Analyst Call Prepared Remarks Transcript
5 months ago seekingalpha.com
Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript
Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript
6 months ago seekingalpha.com
Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript
Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript
9 months ago seekingalpha.com
Syntara Limited (PMXSF) Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates Transcript
Syntara Limited (PMXSF) Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates Transcript
11 months ago seekingalpha.com
Syntara Limited (PMXSF) Discusses Progress and Future Plans for Skin Scarring Program Transcript
Syntara Limited (OTCPK:PMXSF) Discusses Progress and Future Plans for Skin Scarring Program November 25, 2025 7:00 PM EST Company Participants Gary Phillips - CEO, MD & Director Wolfgang Jarolimek -…
11 months ago seekingalpha.com
Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript
Syntara Limited (OTCPK:PMXSF) Shareholder/Analyst Call November 19, 2025 6:00 PM EST Company Participants Cameron Billingsley - Company Secretary & General Counsel Kathleen M. Metters Gary Phillips -…